These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 33934604)
1. Discovery of Novel and Potent Li Z; Cai G; Fang F; Li W; Fan M; Lian J; Qiu Y; Xu X; Lv X; Li Y; Zheng R; Wang Y; Li Z; Zhang G; Liu Z; Huang Z; Zhang L J Med Chem; 2021 May; 64(9):5551-5576. PubMed ID: 33934604 [No Abstract] [Full Text] [Related]
2. Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like Effects. Burgdorf JS; Zhang XL; Stanton PK; Moskal JR; Donello JE Int J Neuropsychopharmacol; 2022 Dec; 25(12):979-991. PubMed ID: 35882204 [TBL] [Abstract][Full Text] [Related]
3. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis. Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014 [No Abstract] [Full Text] [Related]
4. Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity. Sakurai F; Yukawa T; Kina A; Murakami M; Takami K; Morimoto S; Seto M; Kamata M; Yamashita T; Nakashima K; Narita N; Bettini E; Ugolini A; Corsi M; Hasui T Bioorg Med Chem; 2022 Feb; 56():116576. PubMed ID: 35051811 [TBL] [Abstract][Full Text] [Related]
5. An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors. Jambrina E; Cerne R; Smith E; Scampavia L; Cuadrado M; Findlay J; Krambis MJ; Wakulchik M; Chase P; Brunavs M; Burris KD; Gallagher P; Spicer TP; Ursu D J Biomol Screen; 2016 Jun; 21(5):468-79. PubMed ID: 26838761 [TBL] [Abstract][Full Text] [Related]
6. Positive modulation of NMDA receptors by AGN-241751 exerts rapid antidepressant-like effects via excitatory neurons. Pothula S; Liu RJ; Wu M; Sliby AN; Picciotto MR; Banerjee P; Duman RS Neuropsychopharmacology; 2021 Mar; 46(4):799-808. PubMed ID: 33059355 [TBL] [Abstract][Full Text] [Related]
7. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests. Andreasen JT; Gynther M; Rygaard A; Bøgelund T; Nielsen SD; Clausen RP; Mogensen J; Pickering DS Neurosci Lett; 2013 Jun; 546():6-10. PubMed ID: 23643996 [TBL] [Abstract][Full Text] [Related]
8. Allosteric modulators of NMDA receptors: multiple sites and mechanisms. Zhu S; Paoletti P Curr Opin Pharmacol; 2015 Feb; 20():14-23. PubMed ID: 25462287 [TBL] [Abstract][Full Text] [Related]
9. NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites. Goldsmith PJ Curr Top Med Chem; 2019; 19(24):2239-2253. PubMed ID: 31660834 [TBL] [Abstract][Full Text] [Related]
10. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors. Paul SM; Doherty JJ; Robichaud AJ; Belfort GM; Chow BY; Hammond RS; Crawford DC; Linsenbardt AJ; Shu HJ; Izumi Y; Mennerick SJ; Zorumski CF J Neurosci; 2013 Oct; 33(44):17290-300. PubMed ID: 24174662 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid. Irvine MW; Fang G; Sapkota K; Burnell ES; Volianskis A; Costa BM; Culley G; Collingridge GL; Monaghan DT; Jane DE Eur J Med Chem; 2019 Feb; 164():471-498. PubMed ID: 30622023 [TBL] [Abstract][Full Text] [Related]
16. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms. Wei IH; Chen KT; Tsai MH; Wu CH; Lane HY; Huang CC J Agric Food Chem; 2017 Dec; 65(49):10792-10803. PubMed ID: 29161812 [TBL] [Abstract][Full Text] [Related]
17. Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M Grannan MD; Mielnik CA; Moran SP; Gould RW; Ball J; Lu Z; Bubser M; Ramsey AJ; Abe M; Cho HP; Nance KD; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW; Jones CK ACS Chem Neurosci; 2016 Dec; 7(12):1706-1716. PubMed ID: 27617634 [TBL] [Abstract][Full Text] [Related]
18. Pregn-5-en-3β-ol and androst-5-en-3β-ol dicarboxylic acid esters as potential therapeutics for NMDA hypofunction: In vitro safety assessment and plasma stability. Matousova M; Soucek R; Tloustova E; Slavikova B; Chodounska H; Mertlikova-Kaiserova H; Kudova E Steroids; 2019 Jul; 147():4-9. PubMed ID: 30296546 [TBL] [Abstract][Full Text] [Related]
19. Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action. Burnell ES; Irvine M; Fang G; Sapkota K; Jane DE; Monaghan DT J Med Chem; 2019 Jan; 62(1):3-23. PubMed ID: 29446949 [TBL] [Abstract][Full Text] [Related]
20. Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis. Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E; García-Serra A; Maudes E; Pedreño M; Paul S; Doherty J; Quirk M; Dai J; Gasull X; Lewis M; Dalmau J Brain; 2020 Sep; 143(9):2709-2720. PubMed ID: 32830245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]